Literature DB >> 33966651

Characteristics of Clinical Trials Launched Early in the COVID-19 Pandemic in the US and in France.

Véronique Raimond, Julien Mousquès, Jerry Avorn, Aaron S Kesselheim.   

Abstract

Based on hierarchical classification and logistic regression of early US and French COVID-19 clinical trials we show that despite the registration of a large number of trials, only a minority had characteristics usually associated with providing robust and relevant evidence.

Entities:  

Keywords:  COVID-19; Clinical Trial; France; Hierarchical Classification; United States

Mesh:

Year:  2021        PMID: 33966651     DOI: 10.1017/jme.2021.19

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  1 in total

1.  How informative were early SARS-CoV-2 treatment and prevention trials? a longitudinal cohort analysis of trials registered on ClinicalTrials.gov.

Authors:  Nora Hutchinson; Katarzyna Klas; Benjamin G Carlisle; Jonathan Kimmelman; Marcin Waligora
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.